Humacyte, Inc.
$0.70
The Read: Humacyte’s stock fell sharply on repeated Symvess revenue misses and a dilutive $20 million offering, but later surged nearly 80% after securing a $1.
Price
Overlays
Panel
HUMA
Hover to view data
No Data
By creating an account you agree to our Terms of Service and Privacy Policy.
$0.70
The Read: Humacyte’s stock fell sharply on repeated Symvess revenue misses and a dilutive $20 million offering, but later surged nearly 80% after securing a $1.
No Data